Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System
Journal
Acta Haematologica
ISSN
0001-5792
1421-9662
Date Issued
2020
Author(s)
Nader Omidvar
Nilgun Tekin
Flavia Bruna
Botond Timar
Eva Gagyi
Ranjan Basak
Chirayu Auewarakul
Narongrit Sritana
Juliano Julio Cerci
Mark Pierre Dimamay
Tamas Gyorke
Francisca Redondo
Reena Nair
Charity Gorospe
Diana Paez
Stefano Fanti
Hilal Ozdag
Rose Ann Padua
Robert Carr
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Subjects
adaptor proteins, signal transducing
;
adult
;
aged
;
antineoplastic combined chemotherapy protocols
;
cyclophosphamide
;
doxorubicin
;
female
;
humans
;
lim domain proteins
;
lymphoma, large b-cell, diffuse
;
male
;
middle aged
;
positron emission tomography computed tomography
;
prednisone
;
proto-oncogene proteins
;
rituximab
;
tumor necrosis factor receptor superfamily, member 9
;
vincristine
;
antineoplastic agent
;
antineoplastic agent
;
cyclophosphamide
;
doxorubicin
;
lim protein
;
lmo2 protein, human
;
oncoprotein
;
prednisone
;
r-chop protocol
;
rituximab
;
signal transducing adaptor protein
;
tnfrsf9 protein, human
;
tumor necrosis factor receptor superfamily member 9
;
vincristine
;
cancer chemotherapy
;
cancer prognosis
;
cancer recurrence
;
cancer survival
;
diffuse large b cell lymphoma
;
event free survival
;
gene
;
gene expression
;
genetic screening
;
human
;
international prognostic index
;
letter
;
lmo2 gene
;
overall survival
;
patient identification
;
positron emission tomography-computed tomography
;
priority journal
;
tnfrsf9 gene
;
tumor microenvironment
;
two gene scoring system
;
adult
;
aged
;
clinical trial
;
diagnostic imaging
;
diffuse large b cell lymphoma
;
female
;
male
;
metabolism
;
middle aged
;
mortality
;
multicenter study